Concomitant psychotropic medication use during treatment of schizophrenia patients: Longitudinal results from the CATIE study

Medicine and Dentistry

• Predictor 100%
• Antidepressant 89%
• Hypnotic Sedative Agent 80%
• Patient 70%
• Anxiolytic 50%
• Therapeutic Procedure 50%
• Inpatient 50%
• Depression 40%
• Alcohol Abuse 40%
• Medication 30%
• Typical Antipsychotic 20%
• Drug Therapy 20%
• Study Participant 20%
• Treatment Duration 20%
• Symptom 20%
• Treatment of Schizophrenia 20%
• Dependent Personality Disorder 20%
• Insomnia 10%
• Diagnosis 10%
• Body Mass Index 10%
• Anxiety Disorder 10%
• Post-Hoc Analysis 10%
• Akathisia 10%
• Diagnosis of Depression 10%
• Age 10%
• Positive Syndrome 10%
• Race 10%
• Clinician 10%
• Anxiety 10%
• Female 10%

Neuroscience

• Hypnotic 70%
• Depression 50%
• Anxiolytic 50%
• Dementia Praecox 30%
• Antipsychotic 20%
• Dependent Personality Disorder 20%
• Body Mass Index 10%
• Akathisia 10%
• Positive Syndrome 10%
• Anxiety 10%
• Insomnia 10%
• Race 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Hypnotic Sedative Agent 80%
• Psychotropic Agent 50%
• Depression 40%
• Schizophrenia 30%
• Controlled Clinical Trial 20%
• Symptom 20%
• Dependent Personality Disorder 20%
• Akathisia 10%
• Insomnia 10%
• Positive Syndrome 10%